Baupost Group
13F Holdings and Portfolio Analysis
Seth Klarman 2014 Q1 13F holdings, quarterly changes, portfolio value trend and position weight distribution.
Baupost Group Overview
Baupost Group held 20 stocks in 2014 Q1, with total market value around $4.14B.
Baupost Group's top five holdings in 2014 Q1: Micron Technology, Inc.(MU) 29.54%, VIASAT INC(VSAT) 19.02%, THERAVANCE INC 15.49%, CHENIERE ENERGY INC 7.57%, IDENIX PHARMACEUTICALS INC 7.32%.
- Portfolio Value
- $4.14B
- Current Holdings
- 20 stocks
- New / Increased
- 4 / 4
- Reduced / Exited
- 2 / 3
Current Holdings
| 1 | Micron Technology, Inc.MU | 1.22 | 29.54% | 51.66 - | $23.66 | $971.00 +4003.97% | $15.43 | 0.00 | 1.00 | +$49.36B+6191.47% | Held |
| 2 | VIASAT INCVSAT | 0.79 | 19.02% | 11.40 +2.40% | $69.04 | - | $71.30 | +0.27 | 1.00 | -$0.03B-3.17% | Increased |
| 3 | THERAVANCE INCCUSIP 88338T104 | 0.64 | 15.49% | 20.71 +2.79% | $30.94 | - | $38.32 | +0.56 | 1.00 | -$0.15B-19.26% | Increased |
| 4 | CHENIERE ENERGY INCCUSIP 16411R208 | 0.31 | 7.57% | 5.66 | $55.35 | - | $55.35 | +5.66 | 0.25 | $0.00B0.00% | New |
| 5 | IDENIX PHARMACEUTICALS INCCUSIP 45166R204 | 0.30 | 7.32% | 53.33 +44.49% | $5.68 | - | $4.65 | +16.42 | 1.00 | +$0.05B+21.99% | Increased |
| 6 | BP PLC-SPONS ADRBP | 0.15 | 3.68% | 3.17 -44.12% | $48.10 | - | $41.82 | -2.50 | 1.00 | +$0.02B+15.01% | Reduced |
| 7 | PBF ENERGY INCCUSIP 69318G106 | 0.14 | 3.38% | 5.42 +174.04% | $25.80 | - | $26.28 | +3.44 | 0.75 | -$0.00B-1.81% | Increased |
| 8 | KERYX BIOPHARMACEUTICALS INCCUSIP 492515101 | 0.11 | 2.60% | 6.31 | $17.04 | - | $17.04 | +6.31 | 0.25 | $0.00B0.00% | New |
| 9 | NOVAGOLD RES INCCUSIP 66987E206 | 0.08 | 1.89% | 21.69 - | $3.61 | - | $2.11 | 0.00 | 1.00 | +$0.03B+71.09% | Held |
| 10 | CHIPMOS TECH BERMUDA LTDCUSIP G2110R114 | 0.07 | 1.75% | 3.28 - | $22.06 | - | $19.13 | 0.00 | 1.00 | +$0.01B+15.30% | Held |
| 11 | CITIGROUP INCCUSIP 172967226 | 0.07 | 1.62% | 104.25 - | $0.64 | - | $0.77 | 0.00 | 1.00 | -$0.01B-16.95% | Held |
| 12 | RF MICRODEVICES INCCUSIP 749941100 | 0.05 | 1.25% | 6.58 | $7.88 | - | $7.88 | +6.58 | 0.25 | $0.00B0.00% | New |
| 13 | TRINQUINT SEMICONDUCTOR INCCUSIP 89674K103 | 0.05 | 1.24% | 3.83 | $13.39 | - | $13.39 | +3.83 | 0.25 | $0.00B0.00% | New |
| 14 | KINDRED BIOSCIENCES INCCUSIP 494577109 | 0.05 | 1.24% | 2.76 -4.69% | $18.53 | - | $11.17 | -0.14 | 0.50 | +$0.02B+65.89% | Reduced |
| 15 | SYNERON MEDICAL LTDCUSIP M87245102 | 0.05 | 1.20% | 4.00 - | $12.45 | - | $8.70 | 0.00 | 1.00 | +$0.01B+43.10% | Held |
| 16 | ALLIANCE ONE INTL INCCUSIP 018772103 | 0.02 | 0.45% | 6.38 - | $2.92 | - | $3.80 | 0.00 | 1.00 | -$0.01B-23.16% | Held |
| 17 | AMERICAN INTL GROUP INCCUSIP 026874156 | 0.01 | 0.32% | 0.66 - | $20.44 | - | $18.24 | 0.00 | 1.00 | +$0.00B+12.06% | Held |
| 18 | NOVACOPPER INCCUSIP 66988K102 | 0.01 | 0.16% | 5.01 - | $1.35 | - | $1.75 | 0.00 | 1.00 | -$0.00B-22.85% | Held |
| 19 | AVEO PHARMACEUTICALS INCCUSIP 053588109 | 0.01 | 0.14% | 3.83 - | $1.50 | - | $2.50 | 0.00 | 1.00 | -$0.00B-40.20% | Held |
| 20 | ALON USA PARTNERS LPCUSIP 02052T109 | 0.01 | 0.13% | 0.33 - | $16.66 | - | $16.66 | 0.00 | 0.50 | $0.00B0.00% | Held |
Showing 1-20 of 20
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.
Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.
Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.
Exited Holdings
Stocks no longer disclosed in the current 13F portfolio for 2014 Q1.
| 1 | FIDELITY NATIONAL FINANCIALCUSIP 31620R105 | 1.97 | 0.25 | $32.45 | $32.45 | $0.00B0.00% |
| 2 | ROVI CORP COMCUSIP 779376102 | 2.16 | 0.75 | $22.84 | $19.69 | -$0.01B-13.79% |
| 3 | ENZON PHARMACEUTICALS INCCUSIP 293904108 | 4.34 | 0.75 | $2.00 | $1.16 | -$0.00B-42.00% |
Showing 1-3 of 3
Exited holdings are stocks disclosed in the previous report period but no longer disclosed in the current 13F portfolio.
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis uses the same weighted cost-pool method as current holdings. Estimated exit price uses the current report period weighted report price when available, otherwise the previous report price; it does not represent the actual sale price.
Exit return shows estimated dollar return on top and percentage return below.
Portfolio Visuals
Track portfolio value, position weights and Top 10 history.